Our findings support our hypothesis that the newly identified JAK3-INSL3 fusion transcript contributes to constitutive JAK3 activation, and this could be an additional mechanism of constitutive JAK3 activation in MF/SS CTCL. Here, INSL3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.